MEI Pharma, Inc.

Historical 13F Holders

Symbol
LITS
CUSIP
55279B301
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 55279B301 since 12/18/2024, newest first.

Filer % of Class Filed
Alexander Schornstein 13G/A Amendment 3 0% 8/3/2026
Event 6/30/2026
Citadel Advisors LLC 13G/A Amendment 1
3.9% 2/17/2026
Event 12/31/2025
Alexander Schornstein 13G/A Amendment 2 10.0% 12/22/2025
Event 12/18/2025
Vanguard Group Inc 13G/A Amendment 2 2.0% 10/31/2025
Event 9/30/2025
Alexander Schornstein 13G/A Amendment 1 13.3% 9/10/2025
Event 9/9/2025
Alexander Schornstein 13G 6.5% 8/12/2025
Event 8/11/2025
Citadel Advisors LLC 13G
10.0% 7/29/2025
Event 7/22/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 2.00 k $2.64 k
2026 Q2 40 5.89 M $5.43 M
2026 Q1 39 5.89 M $6.83 M
2025 Q4 43 8.27 M $10.9 M
2025 Q3 54 10.1 M $24.5 M
2025 Q2 32 2.61 M $6.45 M
2025 Q1 35 2.67 M $5.85 M
2024 Q4 35 2.70 M $6.65 M
2024 Q3 32 2.74 M $7.81 M
2024 Q2 38 2.74 M $7.96 M
2024 Q1 39 2.89 M $11.5 M
2023 Q4 34 3.17 M $18.4 M
2023 Q3 31 2.53 M $17.7 M
2023 Q2 30 2.28 M $15.0 M